ADR CP: the Adverse Drug Risk Control Panel of SCHOLZ DataBank - test now the Beta-Version!
10/03/2021
Why Patients should ask Doctors for side effects and interactions and Doctors should have an answer
Experimental Research for potential COVID-19 Medication successful
05/30/2021
When decision support is needed beyond the prescriber information: the apixaban/Eliquis case
05/02/2021
Easy Prescribing of controlled Drugs
04/18/2021
The MDDI Technology of SCHOLZ DataBank and its Impact on Drug Safety when prescribing Vortioxetine
11/07/2020
The international Research Effort of SCHOLZ DataBank and its Impact on Drug Safety when prescribing
11/05/2020
Roughly 10% of Drugs may contribute to increased Risk of Cardiac Arrhythmia due to QT Prolongation
10/27/2020